Saturday, 17 October 2026European Markets

SPORTING Stock Over 18% Down So Far On Wednesday

Loading stream...

(VIANEWS) - Shares of SPORTING (PSI: SCP.LS) dropped by a staggering 18.75% to €0.65 at 14:28 EST on Wednesday, following the last session's downward trend. PSI is rising 0.41% to €6,083.83, after five consecutive sessions in a row of gains. This seems, as yet, a somewhat bullish trend exchanging session today.

About SPORTING

Sporting Clube de Portugal - Futebol, SAD operates sports clubs in Portugal. The company also engages in the sale of tickets for games; advertising and sponsorships activities; and provision of television rights. Sporting Clube de Portugal - Futebol, SAD was founded in 1907 and is headquartered in Lisbon, Portugal.

Earnings Per Share

As for profitability, SPORTING has a trailing twelve months EPS of €0.021.

PE Ratio

SPORTING has a trailing twelve months price to earnings ratio of 30.95. Meaning, the purchaser of the share is investing €30.95 for every euro of annual earnings.

Volume

Today's last reported volume for SPORTING is 101 which is 75.72% below its average volume of 416.

More news about SPORTING (SCP.LS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com